Atypical Bacterial Pneumonia
- PMID: 30335272
- Bookshelf ID: NBK532239
Atypical Bacterial Pneumonia
Excerpt
Pneumonia is a lower respiratory tract infection that primarily affects the pulmonary parenchyma. Viruses, fungi, and bacteria can all cause pneumonia. Atypical bacterial pneumonia is caused by bacterial species less frequently associated with pneumonia compared to typical bacterial species, such as Gram-positive Streptococcus pneumoniae or Staphylococcus aureus. These atypical bacteria are also more difficult to detect using traditional Gram stain and standard culture methods. Examples of atypical bacteria include Mycoplasma pneumoniae, Chlamydia (formerly Chlamydophila) pneumoniae, and Legionella species. Similar to typical bacterial pneumonia, the severity of pneumonia can range from mild to life-threatening, with uncomplicated disease resolving with outpatient antibiotics and complicated cases progressing to septic shock, acute respiratory distress syndrome, and death. Atypical bacterial pneumonia affects all age groups and can account for up to 40% of community-acquired pneumonia cases. M. pneumoniae alone is estimated to account for over 2 million cases and 100,000 hospitalizations in the United States. Atypical bacterial pneumonia can cause mortality in both adults and children, and epidemics may occur every few years. Atypical bacteria are known to cause a disproportionate disease burden in children older than 5 and adolescents. These bacteria can initially present subacutely and progress to constitutional symptoms. Proper evaluation of suspected atypical bacterial pneumonia, including a detailed history, physical examination, and targeted investigations, is crucial for the interdisciplinary management of this condition.
Please see StatPearls' companion resource, "
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Prognosis
- Complications
- Deterrence and Patient Education
- Pearls and Other Issues
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Miyashita N. Atypical pneumonia: Pathophysiology, diagnosis, and treatment. Respir Investig. 2022 Jan;60(1):56-67. - PubMed
-
- Jain V, Vashisht R, Yilmaz G, Bhardwaj A. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jul 31, Pneumonia Pathology. - PubMed
-
- Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician. 2004 Apr 01;69(7):1699-706. - PubMed
-
- Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019 Nov;57(11) - PMC - PubMed
-
- Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997 Aug 11-25;157(15):1709-18. - PubMed
Publication types
LinkOut - more resources
Full Text Sources